Pomezia, Italy

Raffaello Giorgi


Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 11(Granted Patents)


Location History:

  • late of Pomezia, IT (2003)
  • late of Pisa, IT (2004)

Company Filing History:


Years Active: 2003-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Raffaello Giorgi: Innovator in Pharmaceutical Chemistry

Introduction

Raffaello Giorgi is a notable inventor based in Pomezia, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 3 patents, Giorgi has focused on developing compounds that have important therapeutic applications.

Latest Patents

Giorgi's latest patents include groundbreaking work on monocyclic compounds with four bifunctional residues that exhibit NK-2 antagonist action. Additionally, he has developed a process for the preparation of zofenopril calcium salt. This process involves several steps, including the reaction of S(−)-3-benzoylthio-2-methylpropanoic acid chloride with cis-4-phenylthio-L-proline in water at a specific pH, followed by salification and conversion to the calcium salt through a carefully controlled reaction.

Career Highlights

Throughout his career, Raffaello Giorgi has worked with prominent companies in the pharmaceutical industry, including Menarini Ricerche S.p.a. and Menarini Richerche S.p.a. His work has been instrumental in advancing the development of new therapeutic agents.

Collaborations

Giorgi has collaborated with esteemed colleagues such as Antonio Giachetti and Carlo Mannucci. These partnerships have contributed to the success of his research and the advancement of innovative solutions in the pharmaceutical sector.

Conclusion

Raffaello Giorgi's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the field, paving the way for future innovations in drug development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…